跳至主要内容
临床试验/EUCTR2006-002084-49-GB
EUCTR2006-002084-49-GB进行中(未招募)1 期

Vascular function in impaired glucose tolerance - effect of pioglitazone - Vascular function in IGT

Belfast City Hospital Trust0 个研究点目标入组 104 人开始时间: 2006年9月18日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
104

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

入选标准

  • Subjects will have impaired glucose tolerance.
  • They should be aged 18-70 years.
  • Body mass index should be >25.
  • They should be otherwise fit and well.
  • They may have hypertension controlled <140/90 mmHg on one anti-hypertensive agent which will be omitted on the day of the study.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Blood pressure >140/90 mmHg or requiring more than one anti-hypertensive agent to be controlled <140/90 mmHg.
  • History of ischaemic heart disease or cerebrovascular disease.
  • Cardiac failure.
  • Renal failure (GFR <30 ml/min).
  • Liver impairment (ALT> x2 normal).
  • Women who are pregnant or breastfeeding.

研究者

发起方
Belfast City Hospital Trust

相似试验